
Antithesis
Pioneering autonomous software testing, they empower users to enhance software development speed and quality significantly.
USD | 2022 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Antithesis is a company focused on revolutionizing software quality assurance (QA) through autonomous testing. The company has developed a cutting-edge platform that identifies bugs in software within a controlled environment, ensuring that all bugs are reproducible. This approach significantly enhances the confidence and productivity of development teams by providing a reliable method for detecting and addressing software faults. Antithesis primarily serves software development teams and companies that require high levels of software reliability and fault tolerance. Operating in the software QA market, the company's business model revolves around offering its autonomous testing platform as a service. Revenue is generated through subscription fees for access to the platform, as well as potential consulting services to help integrate the platform into existing workflows. The platform's first offering specializes in finding fault tolerance bugs, which are failures that occur under specific network, hardware, or timing conditions. By automating the bug detection process, Antithesis aims to reduce the time and resources spent on manual testing, thereby increasing overall productivity and software reliability.
Keywords: autonomous testing, software QA, bug detection, reproducible bugs, fault tolerance, controlled environment, software reliability, productivity, subscription service, software development.